These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 33150193)

  • 1. Two Siblings With Valproate-Related Hyperammonemia and Novel Mutations in Glutamine Synthetase
    Bennett J; Gilkes C; Klassen K; Kerr M; Khan A
    Child Neurol Open; 2020; 7():2329048X20967880. PubMed ID: 33150193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of glutamine synthetase gene polymorphisms on the development of hyperammonemia during valproic acid-based therapy.
    Inoue K; Takahashi T; Yamamoto Y; Suzuki E; Takahashi Y; Imai K; Inoue Y; Hirai K; Tsuji D; Itoh K
    Seizure; 2015 Dec; 33():76-80. PubMed ID: 26599579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of carglumic acid in valproate-induced hyperammonemia: 25 pediatric cases.
    Palomino Pérez LM; Martín-Rivada Á; Cañedo Villaroya E; García-Peñas JJ; Cuervas-Mons Vendrell M; Pedrón-Giner C
    JIMD Rep; 2020 Sep; 55(1):3-11. PubMed ID: 32905024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carglumic acid enhances rapid ammonia detoxification in classical organic acidurias with a favourable risk-benefit profile: a retrospective observational study.
    Valayannopoulos V; Baruteau J; Delgado MB; Cano A; Couce ML; Del Toro M; Donati MA; Garcia-Cazorla A; Gil-Ortega D; Gomez-de Quero P; Guffon N; Hofstede FC; Kalkan-Ucar S; Coker M; Lama-More R; Martinez-Pardo Casanova M; Molina A; Pichard S; Papadia F; Rosello P; Plisson C; Le Mouhaer J; Chakrapani A
    Orphanet J Rare Dis; 2016 Mar; 11():32. PubMed ID: 27030250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Valproic acid rechallenge after valproate-induced hyperammonemic encephalopathy.
    Mithani F; Cullum S; Chacko R
    Proc (Bayl Univ Med Cent); 2020 Jul; 33(3):471-472. PubMed ID: 32675993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unusual cause of hyperammonemia in two cases with short-term and long-term valproate therapy successfully treated by single dose carglumic acid.
    Kasapkara CS; Kanğın M; Taş FF; Topçu Y; Demir R; Ozbek MN
    J Pediatr Neurosci; 2013 Sep; 8(3):250-2. PubMed ID: 24470826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carglumic Acid Treatment of a Patient with Recurrent Valproic Acid-induced Hyperammonemia: A Rare Case Report.
    Sattar Y; Wasiq S; Yasin W; Khan AM; Adnan M; Shrestha S; Patel NB; Latchana S
    Cureus; 2018 Sep; 10(9):e3292. PubMed ID: 30443462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Valproate-induced hyperammonemic encephalopathy in a neonate: treatment with carglumic acid].
    Fernández Colomer B; Rekarte García S; García López JE; Pérez González C; Montes Granda M; Coto Cotallo GD
    An Pediatr (Barc); 2014 Oct; 81(4):251-5. PubMed ID: 24315420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of carglumic acid with or without ammonia scavengers on hyperammonaemia in acute decompensation episodes of organic acidurias.
    Chakrapani A; Valayannopoulos V; Segarra NG; Del Toro M; Donati MA; García-Cazorla A; González MJ; Plisson C; Giordano V
    Orphanet J Rare Dis; 2018 Jun; 13(1):97. PubMed ID: 29925411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of encephalopathy by means of valproic acid with carglumic acid: two case reports and a review of the literature].
    Nava-Mateos JJ; Roiz-Rey P; Diaz Alvarez-Mediavilla J; Cebrian-Novella D; Gomez-Del Olmo V; Ceberio-Hualde L
    Rev Neurol; 2017 Nov; 65(9):409-414. PubMed ID: 29071700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First report of carglumic acid in a patient with citrullinemia type 1 (argininosuccinate synthetase deficiency).
    Kose E; Kuyum P; Aksoy B; Häberle J; Arslan N; Ozturk Y
    J Clin Pharm Ther; 2018 Feb; 43(1):124-128. PubMed ID: 28741715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of levocarnitine, lactulose, and combination therapy for the treatment of valproic acid-induced hyperammonemia in critically ill patients.
    Nicholson C; Fowler M; Mullen C; Cunningham B
    Epilepsy Res; 2021 Dec; 178():106806. PubMed ID: 34763268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum and CSF glutamine levels in valproate-related hyperammonemic encephalopathy.
    Vossler DG; Wilensky AJ; Cawthon DF; Kraemer DL; Ojemann LM; Caylor LM; Morgan JD
    Epilepsia; 2002 Feb; 43(2):154-9. PubMed ID: 11903461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. L-Arginine in the treatment of valproate overdose - five clinical cases.
    Schrettl V; Felgenhauer N; Rabe C; Fernando M; Eyer F
    Clin Toxicol (Phila); 2017 Apr; 55(4):260-266. PubMed ID: 28152637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Valproic acid-induced hyperammonemic encephalopathy in a patient receiving valproic acid monotherapy].
    Yamada H; Shishido T; Mukai T; Araki M; Naka H; Tokinobu H
    Rinsho Shinkeigaku; 2019 May; 59(5):258-263. PubMed ID: 31061301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New developments in the treatment of hyperammonemia: emerging use of carglumic acid.
    Daniotti M; la Marca G; Fiorini P; Filippi L
    Int J Gen Med; 2011 Jan; 4():21-8. PubMed ID: 21403788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homozygous GLUL deletion is embryonically viable and leads to glutamine synthetase deficiency.
    Roifman M; Niles KM; MacNeil L; Blaser S; Noor A; Godoy R; van Mieghem T; Ryan G; Seaward G; Sondheimer N; Mercimek-Andrews S; Schulze A; Hewson S; Ovadia A; Chitayat D; Morgen EK; Hojilla C; Kolomietz E; Watkins N; Häberle J; Shannon P
    Clin Genet; 2020 Dec; 98(6):613-619. PubMed ID: 32888207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pronounced reversible hyperammonemic encephalopathy associated with combined valproate-topiramate therapy in a 7-year-old girl.
    Weise S; Syrbe S; Preuss M; Bertsche A; Merkenschlager A; Bernhard MK
    Springerplus; 2015; 4():276. PubMed ID: 26090323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperammonemic encephalopathy in an adenocarcinoma patient managed with carglumic acid.
    Lazier J; Lupichuk SM; Sosova I; Khan AA
    Curr Oncol; 2014 Oct; 21(5):e736-9. PubMed ID: 25302046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Very Rare Etiology of Hypotonia and Seizures: Congenital Glutamine Synthetase Deficiency.
    Ünal Ö; Ceylaner S; Akın R
    Neuropediatrics; 2019 Feb; 50(1):51-53. PubMed ID: 30440076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.